Isoliquiritigenin Attenuates Staphylococcus aureus Adhesion and Invasion to Counteract Staphylococcus aureus Pathogenicity and Infection
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1686699 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Lili Tian und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science and Veterinary Medicine (Affiliated Animal Hospital), Jinzhou Medical University, Jinzhou, Liaoning, China. Hauptthemen laut MEDLINE: Chalcones, Bacterial Adhesion, Methicillin-Resistant Staphylococcus aureus, Anti-Bacterial Agents. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) is a major clinical challenge due to its virulence and multidrug resistance. Antivirulence strategies targeting key pathogenic mechanisms without affecting bacterial viability provide a promising alternative to conventional antibiotics.
Methods
The inhibitory effect of isoliquiritigenin (ISL) on S. aureus sortase A (SrtA) was assessed using a fluorescence resonance energy transfer assay. Fluorescence quenching and molecular docking analyses were performed to elucidate the binding interaction between ISL and SrtA. Adhesion and biofilm formation were evaluated on fibrinogen- and fibronectin-coated surfaces, and bacterial growth was monitored to confirm non-bactericidal activity. The therapeutic efficacy of ISL was further examined in a murine pneumonia model through bacterial load quantification, histopathological analysis, and survival evaluation.
Results
ISL inhibited SrtA activity in a dose-dependent manner (IC 50 = 13.34 µg/mL), disrupted adhesion and biofilm formation without affecting bacterial growth, and bound reversibly to key catalytic residues of SrtA. In vivo, ISL treatment significantly reduced pulmonary bacterial burden, alleviated tissue damage, and improved survival in infected mice.
Discussion
ISL effectively attenuates MRSA pathogenicity by targeting SrtA-mediated virulence rather than bacterial viability. These results highlight ISL as a promising antivirulence agent and a potential adjuvant for combating antibiotic-resistant S. aureus infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Animal Science and Veterinary Medicine (Affiliated Animal Hospital), Jinzhou Medical University, Jinzhou, Liaoning, China.
- Liaoning Provincial Key Laboratory of Animal Product Quality and Safety, Jinzhou, Liaoning, China.
- Department of Animal Husbandry and Veterinary Medicine, Beijing Vocational College Agriculture, Beijing, China.
- College of Animal Science, Jilin University, Changchun, China.
Zitieren
APA
Tian, L., Sun, J., Jiang, H., Wang, H., Zheng, J., Wang, D., & Zhang, L. (2025). Isoliquiritigenin Attenuates Staphylococcus aureus Adhesion and Invasion to Counteract Staphylococcus aureus Pathogenicity and Infection. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1686699
Vancouver
Tian L, Sun J, Jiang H, Wang H, Zheng J, Wang D, et al. Isoliquiritigenin Attenuates Staphylococcus aureus Adhesion and Invasion to Counteract Staphylococcus aureus Pathogenicity and Infection. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1686699
BibTeX
@article{Tian2025,
author = {Tian, Lili and Sun, Jian and Jiang, Hong and Wang, Hongjun and Zheng, Jian and Wang, Dacheng and Zhang, Libo},
title = {Isoliquiritigenin Attenuates Staphylococcus aureus Adhesion and Invasion to Counteract Staphylococcus aureus Pathogenicity and Infection},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1686699}
}
EUVIMED